Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00059722 · ClinicalTrials.gov registry record · Phase 2

This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

A Phase 2 study of Carcinoma, Non-Small Cell Lung, sponsored by Genzyme, a Sanofi Company.

Completed
Registry status
Phase 2
Development phase
160
Enrollment target
20
Study locations

NCT00059722 is a Phase 2 study of Carcinoma, Non-Small Cell Lung that has completed, run by Genzyme, a Sanofi Company. The registered enrollment target is 160 participants, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (50% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00059722, a Phase 2 study of Carcinoma, Non-Small Cell Lung, has completed, sponsored by Genzyme, a Sanofi Company.

COMPLETED
Registry status
Phase 2
Development phase
160 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

Conditions Studied

Carcinoma, Non-Small Cell Lung

Interventions

  • DRUG Placebo
  • DRUG ZD1839
  • DRUG ZD6474

Study Locations (20)

California

  • Research Site - Los Angeles
  • Research Site - Palm Springs
  • Research Site - San Diego

Florida

  • Research Site - Boca Raton
  • Research Site - Jacksonville
  • Research Site - Orange Park

Missouri

  • Research Site - Saint Loius
  • Research Site - St Louis

New York

  • Research Site - Brooklyn
  • Research Site - New York

Other

  • Research Site - Buenos Aires
  • Research Site - Mendoza

Arkansas

  • Research Site - Pine Bluff

Idaho

  • Research Site - Coeur d'Alene

Illinois

  • Research Site - Chicago

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2003-05
Est. Completion 2007-06
Phase Phase 2

Sponsor

Genzyme, a Sanofi Company

196 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00059722

The ClinicalTrials.gov registry entry for NCT00059722 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 323-participant average among 130 other Carcinoma, Non-Small Cell Lung trials with a reported enrollment target (50% lower). The listed sponsor is Genzyme, a Sanofi Company, which has 196 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carcinoma, Non-Small Cell Lung appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00059722 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Missouri.

Frequently Asked Questions

What is clinical trial NCT00059722 about?

NCT00059722 is a clinical study titled "This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.". The purpose of this study is to compare the efficacy of ZD6474 and ZD1839 in patients with NSCLC after Failure of Prior Platinum-based Chemotherapy.

What is the current status of trial NCT00059722?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2003-05. Estimated completion is 2007-06.

What conditions does trial NCT00059722 study?

This clinical trial studies the following conditions: Carcinoma, Non-Small Cell Lung.

What interventions are being tested in trial NCT00059722?

The interventions under investigation include: Placebo (DRUG), ZD1839 (DRUG), ZD6474 (DRUG).

Who is sponsoring clinical trial NCT00059722?

This trial is sponsored by Genzyme, a Sanofi Company, which has 196 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00059722 being conducted?

This trial has 20 study locations across Arkansas, California, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Carcinoma, Non-Small Cell Lung

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Carcinoma, Non-Small Cell Lung

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.